Literature DB >> 8762277

Breast abscess with lethal septicemia due to Pseudomonas aeruginosa in a patient with AIDS.

B Roca1, C Vilar, E V Pérez, A Sáez-Royuela, E Simón.   

Abstract

OBJECTIVE: The incidence of Pseudomonas aeruginosa in HIV-infected patients has increased over the last years. We describe a case of pseudomonal breast abscess complicated with fatal septicemia in an AIDS patient. CASE REPORT: A 21-year-old woman was admitted for fever, chills, nausea, vomiting and pain in the breast. She had a swelling in the right breast of 3 days duration. HIV infection had been confirmed 6 years earlier. CD4 count was 2/mm3. Surgical drainage produced a blue-green purulent discharge which grew Pseudomonas aeruginosa on culture. Despite cloxacilin, then ceftazidime and amikacin, initial improvement was followed 2 weeks later by nodular pulmonary infiltration with cavitation. P. aeruginosa was recovered from sputum and blood cultures, but stepwise resistance developed and the patient died 3 months after admission. DISCUSSION: Breast abscesses are infrequent in nonlactating women. P. aeruginosa is rarely involved, even in HIV patients. Due to the risk of resistance, prompt administration of appropriate antibiotics is required.

Entities:  

Mesh:

Year:  1996        PMID: 8762277

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

Review 2.  Pseudomonal breast infection.

Authors:  D P Harji; S Rastall; C Catchpole; R Bright-Thomas; S Thrush
Journal:  Ann R Coll Surg Engl       Date:  2010-04       Impact factor: 1.891

3.  Breast infections in non-lactating women.

Authors:  Maha S A Abdelhadi; Huda A Bukharie
Journal:  J Family Community Med       Date:  2005-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.